Core Laboratories Inc. /DE/ (CLB) Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.
Sector: Oil & Gas Field Services, NEC
Industry: Oil & Gas Equipment & Services
Core Laboratories N.V. NYSE:CLB Energy · Oil & Gas Equipment & Services
Mkt Cap $468.94M
Div Yield 0.39%
AH Close $10.22 +0.00% vs close
AH Close $10.22 +0.00% vs close
Mkt Cap $468.94M
Div Yield 0.39%
All Press Release SEC Filings News
Press Release
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
Core Laboratories will release its third quarter 2026 earnings after market close on October 28, 2026.
The company will host its investor conference call the following morning, October 29, 2026, at 7:30 a.m. CDT, led by Chairman and CEO Larry Bruno and CFO Chris Hill.
This is a routine scheduling notice with no financial results or guidance included.
• 25d ago AI analysis › News
Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?
zacks.com • 1mo ago SEC Filing ⚠ 4
CLB: 8-K · leadership change
Kwaku Temeng verbally notified the Core Laboratories board on August 19, 2026 of his intention to resign as a director effective October 1, 2026, and confirmed the resignation in a letter dated August 25, 2026.
Temeng stated the resignation was due to a disagreement with the Board regarding the Company's strategic direction and certain governance practices. He chaired the Nominating Committee and served on the Compensation Committee during more than five years of board service.
The Board believes the primary disagreement involves how the Company conducts succession planning, a process supported by a majority of directors, along with Temeng's concerns about research priorities. A resignation driven by stated board disagreement under Item 5.02 is a governance red flag investors will watch for follow-on boardroom or strategic changes.
SEC 8-K • 2mo ago AI analysis › News
John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value
gurufocus.com • 2mo ago News
Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?
zacks.com • 2mo ago News
Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y
zacks.com • 2mo ago News
Core Laboratories Q2 Earnings Call Highlights
marketbeat.com • 2mo ago SEC Filing ⚠ 3
CLB: 10-Q · periodic report
Core Laboratories reported a significant decline in financial performance for the six months ended June 30, 2026. Revenue decreased 3% year-over-year to $246.4 million, while net income fell 53% to $5.0 million compared to the prior year period.
The company attributed the weakness to ongoing geopolitical conflicts in the Middle East, specifically noting a 15% to 20% reduction in global crude oil cargo movement. This disruption has directly impacted demand for the company's laboratory assay services, particularly affecting trading and maritime transport activities.
Despite the earnings drop, the company continued its capital allocation strategy, repurchasing approximately 266,000 shares for $3.6 million in the first half of the year. Cash and cash equivalents stood at $22.7 million at the end of the quarter, and the company declared a quarterly dividend of $0.01 per share.
SEC 10-Q • 2mo ago AI analysis › News
Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript
seekingalpha.com • 2mo ago News
Core Laboratories (CLB) Q2 Earnings Surpass Estimates
zacks.com • 2mo ago Press Release ⚠ 3
CORE LAB REPORTS SECOND QUARTER 2026 RESULTS
Core Labs reported Q2 revenue of $124.6 million, down 4% year-over-year but up 2% sequentially, amidst ongoing geopolitical headwinds.
GAAP EPS was $0.13, down 42% from the prior year, though the company generated $3.1 million in free cash flow and repurchased approximately 214,000 shares.
The Board declared a $0.01 per share dividend and issued Q3 guidance for revenue between $128.5 million and $135.5 million.
• 2mo ago AI analysis › News
What's in Store for Core Laboratories Stock in Q2 Earnings?
zacks.com • 3mo ago News
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
zacks.com • 3mo ago News
Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?
zacks.com • 3mo ago Press Release
CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
Core Laboratories scheduled its second quarter 2026 earnings release for after the market close on July 29, 2026.
Management will host a conference call to discuss financial and operational results on July 30, 2026, at 8:30 a.m. EDT.
Participants will include Chairman and CEO Larry Bruno, CFO Chris Hill, and SVP Corporate Development and Investor Relations Gwen Gresham.
• 3mo ago AI analysis › Press Release ● Major ⚠ 1
Gulfport Energy and Mobility Global Set to Join S&P SmallCap 600
Core Laboratories will be removed from the S&P SmallCap 600 effective prior to the market open on Thursday, July 2.
S&P Dow Jones Indices stated the company is no longer representative of the small-cap market space, a change that typically forces passive index funds to liquidate holdings.
Mobility Global, a spinoff of S&P Global, will replace Core Laboratories in the index.
• 4mo ago AI analysis › News
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?
zacks.com • 4mo ago News
Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?
zacks.com • 4mo ago SEC Filing
CLB: 8-K · proxy statement
Core Laboratories Inc. held its Annual Meeting of Shareholders on May 12, 2026 in Houston, Texas. The meeting included votes on three proposals: re-election of two Class I Directors, ratification of KPMG LLP as the independent registered public accountant, and an advisory vote on the compensation of named executive officers.
All proposals were approved. Harvey Klingensmith received 35,880,017 votes in favor, while Curtis Anastasio received 39,271,486 votes in favor. The ratification of KPMG LLP as the independent registered public accountant received 41,220,974 votes in favor.
The advisory vote on executive compensation received 38,265,683 votes in favor. There were no significant issues or surprises in the voting results.
SEC 8-K • 5mo ago Press Release ⚠ 3
CORE LAB REPORTS FIRST QUARTER 2026 RESULTS
Core Labs reported Q1 revenue of $121.8 million, down 12% sequentially and flat year-over-year, with a GAAP loss per share of $0.02.
The significant decline in operating income was attributed to geopolitical instability in the Middle East, the Russia-Ukraine conflict, and severe weather disrupting client activity and shipments.
Despite the Q1 shortfall, the company projects Q2 revenue of $123.0 million to $131.0 million and announced a quarterly dividend of $0.01 per share.
• 5mo ago AI analysis › 2 fund position changes (13F filings)